Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA declines to approve Merck and Eisai’s liver cancer combo therapy
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…
Coronavirus tricks the body into attacking brain; common heartburn drugs linked to coronavirus risk
Widely used heartburn drugs that have been linked with numerous complications including higher risk for kidney disease and…
Gilead begins testing inhalable form of remdesivir for COVID-19
The company said the trial will test the drug particularly in those cases where the disease has not progressed to require…
EU secures potential COVID-19 drugs from Roche, Germany’s Merck – source
The deals cover Roche’s arthritis drug RoActemra and Merck’s multiple sclerosis drug Rebif - both seen as potential COVID-19…
Potential COVID-19 vaccine not ‘single solution’ to pandemic, Johnson & Johnson CEO…
Gorsky said it was a good thing other companies are experimenting with different approaches to vaccines, in part because different…
Sami-Sabinsa group’s curcumin c3 complex with bioperine shown to improve cytokine levels
In this clinical trial, researchers studied the effects of the administration of Curcumin C3 Complex and BioPerine in combination…
Cipla launches Cipremi, likely to price it Rs 4,000 per vial
It is looking to supply over 80,000 vials within the first month
Premas Biotech initiates triple antigen VLP COVID-19 vaccine candidate for animal trials
At the moment, it is the only one from India to adopt a triple-antigen approach that is designed to produce an enhanced immune…
Takeda launches IBD medication Kynteles in India
Used to treat ulcerative colitis and Crohn's Disease as well, the drug expands the company’s GI portfolio in the country
Pharma firms initiate steps to curb black marketing of remedisivir
Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with…